Kissebah A H, Alfarsi S, Adams P W, Wynn V
Diabetologia. 1976 Oct;12(5):501-9. doi: 10.1007/BF01219515.
Using I131 VLDL selectively labelled in the B-apoprotein and I125 LDL injected simultaneously into the patient we have derived some quantitative measures of VLDL and LDL metabolism in man. The effects of insulin resistance, associated with idiopathic hypertriglyceridaemia, adult onset diabetes and diabetic lipodystrophy on the metabolic behaviour of these molecules were also assessed. In the normal subjects 72-83% of the total daily plasma VLDL B-apoprotein flux was metabolised via a pathway which involved its ultimate conversion to plasma LDL, while 21-28% was degraded without such conversion. The amount of B-apoprotein metabolised by either of these routes was proportionate to the flux rate and the two pathways accounted for the total VLDL B-apoprotein removed from the plasma. In patients with idiopathic hypertriglyceridaemia and in the adult onset diabetics the total plasma VLDL B-apoprotein flux was higher than normal, indicating increased production of this apoprotein. On the other hand, the flux rate of plasma VLDL B-apoprotein in the patients with diabetic lipodystrophy was normal, suggesting that the increase in the circulating mass of these molecules was due to impaired clearance. In all the patients, however, the fractions of the total flux either converted to LDL or degraded were lower than normal, suggesting that insulin resistance limited the removal of this apoprotein by these pathways. The results also indicate that a fraction of the total VLDL removed from the plasma has been retained in an extravascular compartment, possibly representing VLDL molecules trapped in the vascular structures. In the control and the insulin resistant subjects the quantity of LDL apoprotein catabolised per day agreed closely with the amount derived from VLDL B-apoprotein conversion, suggesting that VLDL-B-apoprotein serves as the main source of LDL apoprotein. In patients with idiopathic hypertriglyceridaemia and in adult onset diabetics the absolute turnover rate of plasma LDL apoprotein was higher than normal, while in the lipodystrophic patients it was reduced. It is suggested that the increase in LDL turnover seen in the former groups could be an additive factor in the deposition of lipid rich material in arterial walls.
将选择性标记于β-载脂蛋白的I131极低密度脂蛋白(VLDL)和I125低密度脂蛋白(LDL)同时注入患者体内,我们得出了一些人体VLDL和LDL代谢的定量指标。还评估了与特发性高甘油三酯血症、成年型糖尿病和糖尿病性脂肪营养不良相关的胰岛素抵抗对这些分子代谢行为的影响。在正常受试者中,每日血浆总VLDLβ-载脂蛋白通量的72 - 83%通过一条涉及其最终转化为血浆LDL的途径进行代谢,而21 - 28%则在未发生这种转化的情况下被降解。通过这两种途径中任何一种代谢的β-载脂蛋白量与通量率成比例,且这两条途径解释了从血浆中清除的总VLDLβ-载脂蛋白。在特发性高甘油三酯血症患者和成年型糖尿病患者中,血浆总VLDLβ-载脂蛋白通量高于正常,表明该载脂蛋白的产生增加。另一方面,糖尿病性脂肪营养不良患者血浆VLDLβ-载脂蛋白的通量率正常,提示这些分子循环量的增加是由于清除受损。然而,在所有患者中,转化为LDL或被降解的总通量部分均低于正常,表明胰岛素抵抗限制了通过这些途径清除该载脂蛋白。结果还表明,从血浆中清除的总VLDL的一部分保留在血管外隔室中,可能代表被困在血管结构中的VLDL分子。在对照组和胰岛素抵抗受试者中,每日分解代谢的LDL载脂蛋白量与从VLDLβ-载脂蛋白转化而来的量密切相符,表明VLDL - β-载脂蛋白是LDL载脂蛋白的主要来源。在特发性高甘油三酯血症患者和成年型糖尿病患者中,血浆LDL载脂蛋白的绝对周转率高于正常,而在脂肪营养不良患者中则降低。有人认为,在前一组中观察到的LDL周转率增加可能是富含脂质物质在动脉壁沉积的一个附加因素。